Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
3(30%)
Results Posted
50%(1 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
3
30%
Ph phase_1
2
20%
Ph phase_2
4
40%
Ph phase_3
1
10%

Phase Distribution

2

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
3(30.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(2)
Terminated(2)
Other(3)

Detailed Status

unknown3
Completed2
Recruiting2
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (20.0%)
Phase 24 (40.0%)
Phase 31 (10.0%)
N/A3 (30.0%)

Trials by Status

unknown330%
completed220%
active_not_recruiting110%
recruiting220%
terminated220%

Recent Activity

3 active trials
Showing 5 of 10
active_not_recruitingphase_2

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

NCT02125786
recruitingphase_2

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

NCT05535166
recruitingnot_applicable

Exploring Radiotherapy of Temporomandibular Joint Arthritis

NCT05716737
completednot_applicable

OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)

NCT02335957
terminatednot_applicable

OPTimizing Irradiation Through Molecular Assesment of Lymph Node After Primary Systemic Treatment

NCT03972696
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT02125786Phase 2

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

Active Not Recruiting
NCT05535166Phase 2

Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Recruiting
NCT05716737Not Applicable

Exploring Radiotherapy of Temporomandibular Joint Arthritis

Recruiting
NCT02335957Not Applicable

OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)

Completed
NCT03972696Not Applicable

OPTimizing Irradiation Through Molecular Assesment of Lymph Node After Primary Systemic Treatment

Terminated
NCT02369939Phase 3

Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy

Unknown
NCT01594099Phase 2

Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women

Unknown
NCT00115453Phase 1

Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma

Terminated
NCT00004659Phase 2

Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors

Unknown
NCT00014755Phase 1

Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis

Completed

All 10 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
10